Menopause

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Published data show that responses from 1-month and 24-hour recall patient reported outcome (PRO) instruments were similar and support that...

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting – Key SABRE Update Also Expected

Flo Health Secures More than $200M Investment from General Atlantic to Revolutionize Women’s Health; First Purely Digital Consumer Women’s Health App to Achieve Unicorn Status

Leading women's health app sets new benchmark in rapidly expanding femtech industry LONDON, July 30, 2024 /PRNewswire/ -- Flo Health, the...

Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership

The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women MENLO...

Talkspace and Labcorp’s Ovia Health Form Women’s Health Coalition to Deliver Accessible, Affordable Solutions to Address Women’s Diverse Health Needs

Conceive, Evernow, FitOn, Nurx, Cove, and Nutrium Join as Founding Members to Support the Coalition’s Focus on Expanding Access to...

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts

$22 million of non-dilutive capital at close provides significant capital to achieve objectives Upon achieving a pre-specified return threshold, XOMA...

error: Content is protected !!